Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

References for PMC Articles for PubMed (Select 21326171)

1.

Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.

Hastings MC, Moldoveanu Z, Julian BA, Novak J, Sanders JT, McGlothan KR, Gharavi AG, Wyatt RJ.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2069-74. doi: 10.2215/CJN.03270410. Epub 2010 Jul 15.

2.

Genetic studies of IgA nephropathy: past, present, and future.

Kiryluk K, Julian BA, Wyatt RJ, Scolari F, Zhang H, Novak J, Gharavi AG.

Pediatr Nephrol. 2010 Nov;25(11):2257-68. doi: 10.1007/s00467-010-1500-7. Epub 2010 Apr 13. Review.

3.

Familial IgA nephropathy in southeastern Kentucky.

Lavigne KA, Woodford SY, Barker CV, Julian BA, Novak J, Moldoveanu Z, Gharavi AG, Wyatt RJ.

Clin Nephrol. 2010 Feb;73(2):115-21.

4.

Effects of heritability, shared environment, and nonshared intrauterine conditions on child and adolescent BMI.

Salsberry PJ, Reagan PB.

Obesity (Silver Spring). 2010 Sep;18(9):1775-80. doi: 10.1038/oby.2009.485. Epub 2010 Jan 7.

PMID:
20057370
5.

Quantitative immunoglobulins in adulthood.

Crisp HC, Quinn JM.

Allergy Asthma Proc. 2009 Nov-Dec;30(6):649-54. doi: 10.2500/aap.2009.30.3292.

PMID:
20031011
6.

IgA nephropathy--the case for a genetic basis becomes stronger.

Kiryluk K, Gharavi AG, Izzi C, Scolari F.

Nephrol Dial Transplant. 2010 Feb;25(2):336-8. doi: 10.1093/ndt/gfp593. Epub 2009 Nov 13. No abstract available.

7.

Genetic epidemiology of BMI and body mass change from adolescence to young adulthood.

North KE, Graff M, Adair LS, Lange EM, Lange LA, Guo G, Gordon-Larsen P.

Obesity (Silver Spring). 2010 Jul;18(7):1474-6. doi: 10.1038/oby.2009.350. Epub 2009 Oct 22.

8.

Multicenter dizygotic twin cohort study confirms two linkage susceptibility loci for body mass index at 3q29 and 7q36 and identifies three further potential novel loci.

Kettunen J, Perola M, Martin NG, Cornes BK, Wilson SG, Montgomery GW, Benyamin B, Harris JR, Boomsma D, Willemsen G, Hottenga JJ, Slagboom PE, Christensen K, Kyvik KO, Sørensen TI, Pedersen NL, Magnusson PK, Andrew T, Spector TD, Widen E, Silventoinen K, Kaprio J, Palotie A, Peltonen L; GenomEUtwin-project.

Int J Obes (Lond). 2009 Nov;33(11):1235-42. doi: 10.1038/ijo.2009.168. Epub 2009 Sep 1.

9.

The impact of pedigree structure on heritability estimates.

Ekstrøm CT.

Hum Hered. 2009;68(4):243-51. doi: 10.1159/000228922. Epub 2009 Jul 22.

PMID:
19622891
10.

Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.

Lin X, Ding J, Zhu L, Shi S, Jiang L, Zhao M, Zhang H.

Nephrol Dial Transplant. 2009 Nov;24(11):3372-5. doi: 10.1093/ndt/gfp294. Epub 2009 Jun 16.

11.

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.

J Clin Invest. 2009 Jun;119(6):1668-77. doi: 10.1172/JCI38468. Epub 2009 May 26.

12.

Increasing heritability of BMI and stronger associations with the FTO gene over childhood.

Haworth CM, Carnell S, Meaburn EL, Davis OS, Plomin R, Wardle J.

Obesity (Silver Spring). 2008 Dec;16(12):2663-8. doi: 10.1038/oby.2008.434. Epub 2008 Oct 9.

PMID:
18846049
13.

Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.

Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA.

J Am Soc Nephrol. 2008 May;19(5):1008-14. doi: 10.1681/ASN.2007091052. Epub 2008 Feb 13.

14.

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.

Kidney Blood Press Res. 2008;31(1):29-37. doi: 10.1159/000112922. Epub 2008 Jan 8. Review.

15.

Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.

Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.

Nephrol Dial Transplant. 2008 Jun;23(6):1931-9. doi: 10.1093/ndt/gfm913. Epub 2008 Jan 4.

16.

IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JC, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J.

J Clin Invest. 2008 Feb;118(2):629-39. doi: 10.1172/JCI33189.

17.

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.

Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.

Pediatr Nephrol. 2007 Dec;22(12):2067-72. Epub 2007 Oct 18.

PMID:
17943324
18.

The genetics of IgA nephropathy.

Beerman I, Novak J, Wyatt RJ, Julian BA, Gharavi AG.

Nat Clin Pract Nephrol. 2007 Jun;3(6):325-38. Review.

PMID:
17525715
19.

IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.

Contrib Nephrol. 2007;157:134-8. Review.

PMID:
17495451
20.

Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.

Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.

Kidney Int. 2007 Jun;71(11):1148-54. Epub 2007 Mar 7.

PMID:
17342176
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk